Table III.
Clinical outcomes at 2 years and in-hospital
| Parameter | DS (n = 202) | CS (n = 414) | P-value |
|---|---|---|---|
| MI | 12 (6.2) | 38 (10.0) | 0.130 |
| TLR | 6 (3.1) | 25 (6.6) | 0.079 |
| TVR | 11 (5.7) | 30 (7.9) | 0.336 |
| ST | 2 (1.0) | 16 (4.2) | 0.040 |
| MACE | 18 (9.2) | 47 (12.3) | 0.265 |
| In-hospital death | 9 (4.5) | 34 (8.2) | 0.086 |
| In-hospital TLR | 3 (1.5) | 6 (1.4) | 0.972 |
Data are n (%). DS – direct stenting, CS – conventional stenting, MI – myocardial infarction, TLR – target lesion revascularization, TVR – target vessel revascularization, ST – stent thrombosis, MACE – major adverse cardiovascular events.